LNA Sante SA
LSE:0OR2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
LNA Sante SA
LSE:0OR2
|
FR |
|
U
|
Unilever PLC
XHAM:UNV0
|
UK |
|
V
|
Veeva Systems Inc
SWB:VEE
|
US |
|
H
|
HSBC Holdings PLC
DUS:HBC1
|
UK |
|
V
|
Vertex Pharmaceuticals Inc
BMV:VRTX
|
US |
Wall St Price Targets
0OR2 Price Targets Summary
LNA Sante SA
According to Wall Street analysts, the average 1-year price target for 0OR2 is 33.59 EUR with a low forecast of 28.66 EUR and a high forecast of 37.24 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0OR2's stock price target?
Price Target
33.59
EUR
According to Wall Street analysts, the average 1-year price target for 0OR2 is 33.59 EUR with a low forecast of 28.66 EUR and a high forecast of 37.24 EUR.
What is the Revenue forecast for LNA Sante SA?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 2 years is 7%.
What is the Operating Income forecast for LNA Sante SA?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 2 years is 12%.
What is the Net Income forecast for LNA Sante SA?
Projected CAGR
17%
Over the last 14 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 2 years is 17%.
